Radiotherapy Market Size, Share, Growth Analysis, By Product & Service (Products, Software & Services), By Technology (Radiotherapy, Linacs), By Application (External Beam Radiotherapy Applications, Internal Beam Radiotherapy/Brachytherapy Applications), By Procedure (Internal Beam Radiotherapy/Brachytherapy, Systemic Radiotherapy), By End User (Hospitals, Independent Radiotherapy Centers), By Region - Industry Forecast 2024-2031

Radiotherapy Market size was valued at USD 6.4 billion in 2022 and is poised to grow from USD 6.73 billion in 2023 to USD 10.01 billion by 2031, growing at a CAGR of 5.10% during the forecast period (2024-2031).

The competitive landscape for the radiotherapy market gives information by competitors. The company's financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance are among the details that are included. The data points mentioned above only pertain to the companies' market focus on radiotherapy. 'Elekta (Sweden) ', 'Accuray Incorporated (USA) ', 'IBA Worldwide (Ion Beam Applications Sa) (Belgium) ', 'ViewRay Technologies, Inc. (USA) ', 'Perspective Therapeutics, Inc. (USA) ', 'Hitachi Ltd. (Japan) ', 'Sumitomo Heavy Industries Ltd. (Japan) ', 'Carl Zeiss Meditec Ag (Germany) ', 'Mim Software Inc. (USA) ', 'Panacea Medical Technologies Pvt. Ltd. (India) ', 'Provision Healthcare (USA) ', 'Mevion Medical Systems (USA) ', 'Optivus Proton Therapy, Inc. (USA) ', 'P-Cure (Israel) ', 'Intraop Medical, Inc. (USA) ', 'Bebig Medical (Germany) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Raysearch Laboratories (Sweden) ', 'Theragenics (USA) ', 'Protom International (USA) ', 'Dosisoft SA (France) ', 'Isoaid (Canada) ', 'Magnettx Oncology Solutions Ltd. (UK) ', 'Brainlab AG (Germany)'

Due to its growing use in the treatment of various cancers, including those of the lung, prostate, breast, colon, liver, thyroid, lymphoma, brain, and spine, external-beam radiation therapy is in extremely high demand. One of the radiation therapy types most frequently used to treat cancer is external-beam radiation therapy. It draws in the high-energy external radiation into the tumour. As a result, this component spurs market expansion.

The global radiotherapy market is experiencing notable trends that are shaping its growth and development. One key trend is the increasing adoption of advanced technologies, such as IMRT, IGRT, and proton therapy. These advancements allow for more precise and targeted treatment delivery, leading to improved outcomes and reduced side effects.

North America dominates the global Radiotherapy market. The region holds a market share revenue of 44.6%. This can be attributed to factors such as well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced technologies. The region has a strong presence of key market players, along with a favorable reimbursement environment, which further contributes to its dominance in the market.